Tumor necrosis family receptor superfamily member 9/tumor necrosis factor receptor-associated factor 1 pathway on hepatitis C viral persistence and natural history

por Peña-Asensio, Julia, Sanz-de-Villalobos, Eduardo, Miquel, Joaquín, Larrubia, Juan Ramón
Publicado 2020

Gamma-Chain Receptor Cytokines & PD-1 Manipulation to Restore HCV-Specific CD8(+) T Cell Response during Chronic Hepatitis C

por Peña-Asensio, Julia, Calvo, Henar, Torralba, Miguel, Miquel, Joaquín, Sanz-de-Villalobos, Eduardo, Larrubia, Juan-Ramón
Publicado 2021

Anti-PD-1/PD-L1 Based Combination Immunotherapy to Boost Antigen-Specific CD8(+) T Cell Response in Hepatocellular Carcinoma

por Peña-Asensio, Julia, Calvo, Henar, Torralba, Miguel, Miquel, Joaquín, Sanz-de-Villalobos, Eduardo, Larrubia, Juan-Ramón
Publicado 2021

Is it possible to stop nucleos(t)ide analogue treatment in chronic hepatitis B patients?

por Moreno-Cubero, Elia, del Arco, Robert T Sánchez, Peña-Asensio, Julia, de Villalobos, Eduardo Sanz, Míquel, Joaquín, Larrubia, Juan Ramón
Publicado 2018

Model to predict on‐treatment restoration of functional HBV‐specific CD8 (+) cell response foresees off‐treatment HBV control in eAg‐negative chronic hepatitis B

por Peña‐Asensio, Julia, Calvo, Henar, Miquel, Joaquín, Sanz‐de‐Villalobos, Eduardo, González‐Praetorius, Alejandro, Torralba, Miguel, Larrubia, Juan‐Ramón
Publicado 2022

Prevalence of hepatocarcinoma-related hepatitis B virus mutants in patients in grey zone of treatment

por Gil-García, Ana Isabel, Madejón, Antonio, Francisco-Recuero, Irene, López-López, Ana, Villafranca, Emiliana, Romero, Miriam, García, Araceli, Olveira, Antonio, Mena, Rocío, Larrubia, Juan Ramón, García-Samaniego, Javier
Publicado 2019